These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28314510)

  • 21. Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic template.
    Ann J; Sun W; Zhou X; Jung A; Baek J; Lee S; Kim C; Yoon S; Hong S; Choi S; Turcios NA; Herold BK; Esch TE; Lewin NE; Abramovitz A; Pearce LV; Blumberg PM; Lee J
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3603-7. PubMed ID: 27317643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonists.
    Kang JM; Kwon SO; Ann J; Blumberg PM; Ha H; Yoo YD; Frank-Foltyn R; Lesch B; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127548. PubMed ID: 32931910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of N-(1-(2-hydroxyethyl)quinolin-2-one)-N'-(1-phenyl-1H-pyrazol-5-yl)methyl) urea as Mode-Selective TRPV1 antagonist.
    Zuo D; Hong M; Jung A; Lee S; Do N; Jung S; Jeon Y; Won Jeong J; Huang G; Li LX; Blumberg PM; Yoon H; Lee Y; Ann J; Lee J
    Bioorg Med Chem Lett; 2024 Mar; 101():129656. PubMed ID: 38355061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists.
    Huang G; Jung A; Li LX; Do N; Jung S; Jeon Y; Zuo D; Thanh La M; Van Manh N; Blumberg PM; Yoon H; Lee Y; Ann J; Lee J
    Bioorg Med Chem Lett; 2024 Jul; 106():129735. PubMed ID: 38588785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation.
    Feng Z; Pearce LV; Zhang Y; Xing C; Herold BK; Ma S; Hu Z; Turcios NA; Yang P; Tong Q; McCall AK; Blumberg PM; Xie XQ
    AAPS J; 2016 Jul; 18(4):898-913. PubMed ID: 27000851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.
    Feng Z; Pearce LV; Xu X; Yang X; Yang P; Blumberg PM; Xie XQ
    J Chem Inf Model; 2015 Mar; 55(3):572-88. PubMed ID: 25642729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
    Ryu H; Jin MK; Kim SY; Choi HK; Kang SU; Kang DW; Lee J; Pearce LV; Pavlyukovets VA; Morgan MA; Tran R; Toth A; Lundberg DJ; Blumberg PM
    J Med Chem; 2008 Jan; 51(1):57-67. PubMed ID: 18072720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
    Xi N; Bo Y; Doherty EM; Fotsch C; Gavva NR; Han N; Hungate RW; Klionsky L; Liu Q; Tamir R; Xu S; Treanor JJ; Norman MH
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5211-7. PubMed ID: 16203144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities.
    Kim NJ; Li FN; Lee JH; Park SG; Kim K; Lim C; Han YT; Yun H; Jung JW; Park HG; Kim HD; Woo BY; Shin SS; Kim SY; Choi JK; Jeong YS; Park Y; Park YH; Kim DD; Choi S; Suh YG
    Chem Asian J; 2013 Feb; 8(2):400-9. PubMed ID: 23208797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of B-region modified diarylalkyl amide analogues as novel TRPV1 antagonists.
    Han YT; Yang SM; Wang XY; Li FN
    Arch Pharm Res; 2014 Apr; 37(4):440-51. PubMed ID: 23943439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of conformationally restricted capsaicin analogues based in the 1, 3, 4-thiadiazole heterocycle reveal a novel family of transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Rebolledo CL; Sotelo-Hitschfeld P; Brauchi S; Olavarría MZ
    Eur J Med Chem; 2013 Aug; 66():193-203. PubMed ID: 23796768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of piperidine carboxamide TRPV1 antagonists.
    Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent and orally efficacious benzothiazole amides as TRPV1 antagonists.
    Besidski Y; Brown W; Bylund J; Dabrowski M; Dautrey S; Harter M; Horoszok L; Hu Y; Johnson D; Johnstone S; Jones P; Leclerc S; Kolmodin K; Kers I; Labarre M; Labrecque D; Laird J; Lundström T; Martino J; Maudet M; Munro A; Nylöf M; Penwell A; Rotticci D; Slaitas A; Sundgren-Andersson A; Svensson M; Terp G; Villanueva H; Walpole C; Zemribo R; Griffin AM
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6205-11. PubMed ID: 22939234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H
    Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.
    Kim MS; Ki Y; Ahn SY; Yoon S; Kim SE; Park HG; Sun W; Son K; Cui M; Choi S; Pearce LV; Esch TE; Deandrea-Lazarus IA; Blumberg PM; Lee J
    Bioorg Med Chem Lett; 2014 Jan; 24(1):382-5. PubMed ID: 24321344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
    Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
    Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis, and Evaluation of Isoquinoline Ureas as TRPV1 Antagonists.
    Gujarati NA; Undem BJ; Korlipara VL
    Med Chem; 2020; 16(2):202-211. PubMed ID: 31241438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
    Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide.
    Nie C; Li Q; Qiao Y; Hu J; Gao M; Wang Y; Qiao Z; Wang Q; Yan L; Qian H
    Eur J Med Chem; 2020 May; 194():112236. PubMed ID: 32217416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.
    Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S
    J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.